EUVIMEDEUVIMED entdecken
Crossref

A Boron-Doped Copper Single-Atom Nanozyme Ameliorates Atopic Dermatitis via Dual Regulation of Thymic Stromal Lymphopoietin Signaling and Receptor Interaction

Pian Yu, Sihui Ma, Quan Liu, Ge Fang iD, Qiang Zheng, Rongxuan Yan, Chi Fang, Guanming Wang, Qiaozhi Cao, Xiang Chen, Jie Li, Cuicui Ge iD und 1 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c08065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Pian Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan410000, China. Hauptthemen laut MEDLINE: Copper, Cytokines, Dermatitis, Atopic, Receptors, Cytokine. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, China Postdoctoral Science Foundation, Science and Technology Innovation Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disorder in which keratinocyte (KC)-derived thymic stromal lymphopoietin (TSLP) orchestrates pathogenic crosstalk between epithelial cells and immune cells. Here, we present a boron-doped copper single-atom nanomaterial (Cu/NC-B) designed to achieve a dual functional blockade of the TSLP signaling axis, offering a more comprehensive therapeutic intervention. Therapeutically, Cu/NC-B significantly alleviated MC903-induced AD-like lesions, showing efficacy comparable to that of crisaborole (CB) with a superior safety profile. Single-cell transcriptomics analysis revealed that Cu/NC-B selectively targets a previously uncharacterized, highly inflammatory KC subpopulation (KC_Spinous_Tslp), thereby disrupting a critical cellular node in AD pathology. At the molecular level, Cu/NC-B exerts its effects through two complementary pathways: epigenetic repression of TSLP via nicotinamide adenine dinucleotide (NAD+)-dependent activation of SIRT1/3 and competitive antagonism of the TSLP receptor (TSLPR). Our work establishes Cu/NC-B as a dual-action nanotherapeutic capable of concurrently suppressing TSLP transcription and disrupting its receptor engagement, thereby proposing a targeted intervention for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperCytokinesDermatitis, AtopicReceptors, CytokineNanostructuresAnimalsThymic Stromal LymphopoietinSignal TransductionMiceHumans

Stichwörter der Autor:innen

ADCu/NC-BNAD+TSLPTh2single-cell transcriptomics

Substanzen

CopperCytokinesThymic Stromal LymphopoietinReceptors, CytokineTSLP protein, mouse

Autor:innen und Institutionen

  • The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan410000, China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, Hunan410000, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan410000, China.
  • Furong Laboratory, Changsha, Hunan410000, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan410000, China.
  • State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) & Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,…

ORCID-Profile: Ge Fang, Cuicui Ge, Cong Peng

Förderung

  • Ministry of Education of the People's Republic of China
  • China Postdoctoral Science Foundation
  • Science and Technology Innovation Program of Hunan Province
  • Scientific Research Program of FuRong Laboratory
  • Natural Science Foundation of?Hunan Province
  • National Natural Science Foundation of China (NSFC)
  • China National Postdoctoral Program for Innovative Talents
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Yu, P., Ma, S., Liu, Q., Fang, G., Zheng, Q., Yan, R., Fang, C., Wang, G., Cao, Q., Chen, X., Li, J., Ge, C., & Peng, C. (2026). A Boron-Doped Copper Single-Atom Nanozyme Ameliorates Atopic Dermatitis via Dual Regulation of Thymic Stromal Lymphopoietin Signaling and Receptor Interaction. ACS Nano. https://doi.org/10.1021/acsnano.6c08065

Vancouver

Yu P, Ma S, Liu Q, Fang G, Zheng Q, Yan R, et al. A Boron-Doped Copper Single-Atom Nanozyme Ameliorates Atopic Dermatitis via Dual Regulation of Thymic Stromal Lymphopoietin Signaling and Receptor Interaction. ACS Nano. 2026. doi:10.1021/acsnano.6c08065

BibTeX
@article{Yu2026,
  author = {Yu, Pian and Ma, Sihui and Liu, Quan and Fang, Ge and Zheng, Qiang and Yan, Rongxuan and Fang, Chi and Wang, Guanming and Cao, Qiaozhi and Chen, Xiang and Li, Jie and Ge, Cuicui and Peng, Cong},
  title = {A Boron-Doped Copper Single-Atom Nanozyme Ameliorates Atopic Dermatitis via Dual Regulation of Thymic Stromal Lymphopoietin Signaling and Receptor Interaction},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c08065}
}
Kostenlos starten →